Literature DB >> 20599900

Severe developmental bone phenotype in ClC-7 deficient mice.

A V Neutzsky-Wulff1, N A Sims, C Supanchart, U Kornak, D Felsenberg, I J Poulton, T J Martin, M A Karsdal, K Henriksen.   

Abstract

Bone development is dependent on the functionality of three essential cell types: chondrocytes, osteoclasts and osteoblasts. If any of these cell types is dysfunctional, a developmental bone phenotype can result. The bone disease osteopetrosis is caused by osteoclast dysfunction or impaired osteoclastogenesis, leading to increased bone mass. In ClC-7 deficient mice, which display severe osteopetrosis, the osteoclast malfunction is due to abrogated acidification of the resorption lacuna. This study sought to investigate the consequences of osteoclast malfunction on bone development, bone structure and bone modeling/remodeling in ClC-7 deficient mice. Bones from wildtype, heterozygous and ClC-7 deficient mice were examined by bone histomorphometry and immunohistochemistry. ClC-7 deficient mice were found to have a severe developmental bone phenotype, characterized by dramatically increased bone mass, a high content of cartilage remnants, impaired longitudinal and radial growth, as well as lack of compact cortical bone development. Indices of bone formation were reduced in ClC-7 deficient mice; however, calcein labeling indicated that mineralization occurred on most trabecular bone surfaces. Osteoid deposition had great regional variance, but an osteopetrorickets phenotype, as observed in oc/oc mice, was not apparent in the ClC-7 deficient mice. A striking finding was the presence of very large abnormal osteoclasts, which filled the bone marrow space within the ClC-7 deficient bones. The development of these giant osteoclasts could be due to altered cell fate of the ClC-7 deficient osteoclasts, caused by increased cellular fusion and/or prolonged osteoclast survival. In summary, malfunctional ClC-7 deficient osteoclasts led to a severe developmental bone phenotype including abnormally large and non-functional osteoclasts. Bone formation paremeters were reduced; however, bone formation and mineralization were found to be heterogenous and continuing. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20599900     DOI: 10.1016/j.ydbio.2010.06.018

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  11 in total

1.  Mutation in Osteoactivin Promotes Receptor Activator of NFκB Ligand (RANKL)-mediated Osteoclast Differentiation and Survival but Inhibits Osteoclast Function.

Authors:  Samir M Abdelmagid; Gregory R Sondag; Fouad M Moussa; Joyce Y Belcher; Bing Yu; Hilary Stinnett; Kimberly Novak; Thomas Mbimba; Matthew Khol; Kurt D Hankenson; Christopher Malcuit; Fayez F Safadi
Journal:  J Biol Chem       Date:  2015-04-02       Impact factor: 5.157

2.  Dental and Cranial Pathologies in Mice Lacking the Cl(-) /H(+) -Exchanger ClC-7.

Authors:  Xin Wen; Rodrigo S Lacruz; Michael L Paine
Journal:  Anat Rec (Hoboken)       Date:  2015-02-27       Impact factor: 2.064

3.  PLEKHM1/DEF8/RAB7 complex regulates lysosome positioning and bone homeostasis.

Authors:  Toshifumi Fujiwara; Shiqiao Ye; Thiago Castro-Gomes; Caylin G Winchell; Norma W Andrews; Daniel E Voth; Kottayil I Varughese; Samuel G Mackintosh; Yunfeng Feng; Nathan Pavlos; Takashi Nakamura; Stavros C Manolagas; Haibo Zhao
Journal:  JCI Insight       Date:  2016-10-20

Review 4.  Bone remodeling: an operational process ensuring survival and bone mechanical competence.

Authors:  Simona Bolamperti; Isabella Villa; Alessandro Rubinacci
Journal:  Bone Res       Date:  2022-07-18       Impact factor: 13.362

5.  Delayed development of specific thyroid hormone-regulated events in transthyretin null mice.

Authors:  Julie A Monk; Natalie A Sims; Katarzyna M Dziegielewska; Roy E Weiss; Robert G Ramsay; Samantha J Richardson
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-10-23       Impact factor: 4.310

6.  Dissociation of bone resorption and bone formation in adult mice with a non-functional V-ATPase in osteoclasts leads to increased bone strength.

Authors:  Kim Henriksen; Carmen Flores; Jesper S Thomsen; Anne-Marie Brüel; Christian S Thudium; Anita V Neutzsky-Wulff; Geerling E J Langenbach; Natalie Sims; Maria Askmyr; Thomas J Martin; Vincent Everts; Morten A Karsdal; Johan Richter
Journal:  PLoS One       Date:  2011-11-07       Impact factor: 3.240

7.  ClC-7/Ostm1 contribute to the ability of tea polyphenols to maintain bone homeostasis in C57BL/6 mice, protecting against fluorosis.

Authors:  Bing-Yun Li; Yan-Hui Gao; Jun-Rui Pei; Yan-Mei Yang; Wei Zhang; Dian-Jun Sun
Journal:  Int J Mol Med       Date:  2017-03-22       Impact factor: 4.101

8.  Activation of Notch3 in osteoblasts/osteocytes causes compartment-specific changes in bone remodeling.

Authors:  Ernesto Canalis; Stefano Zanotti; Lauren Schilling; Tabitha Eller; Jungeun Yu
Journal:  J Biol Chem       Date:  2021-03-24       Impact factor: 5.157

9.  ClC-7 Deficiency Impairs Tooth Development and Eruption.

Authors:  He Wang; Meng Pan; Jinwen Ni; Yanli Zhang; Yutao Zhang; Shan Gao; Jin Liu; Zhe Wang; Rong Zhang; Huiming He; Buling Wu; Xiaohong Duan
Journal:  Sci Rep       Date:  2016-02-01       Impact factor: 4.379

Review 10.  Ostm1 from Mouse to Human: Insights into Osteoclast Maturation.

Authors:  Jean Vacher; Michael Bruccoleri; Monica Pata
Journal:  Int J Mol Sci       Date:  2020-08-05       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.